Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

Manmeet S. Ahluwalia; Ahmad Ozair; Jan Drappatz; Xiaobu Ye; Sen Peng; Matthew Lee; Sanhita Rath; Harshil Dhruv; Yue Hao; Michael E. Berens; Tobias Walbert; Matthias Holdhoff; Glenn J. Lesser; Timothy F. Cloughesy; Andrew E. Sloan; Naoko Takebe; Marta Couce; David M. Peereboom; Burt Nabors; Patrick Y. Wen; Stuart A. Grossman; Lisa R. Rogers

doi:10.1158/1078-0432.CCR-23-4098

Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

Manmeet S. Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil Dhruv, Yue Hao, Michael E. Berens, Tobias Walbert, Matthias Holdhoff, Glenn J. Lesser, Timothy F. Cloughesy, Andrew E. Sloan, Naoko Takebe, Marta Couce, David M. Peereboom, Burt Nabors, Patrick Y. WenStuart A. Grossman, Lisa R. Rogers

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3167-3178
Number of pages	12
Journal	Clinical cancer research : an official journal of the American Association for Cancer Research
Volume	30
Issue number	15
DOIs	https://doi.org/10.1158/1078-0432.CCR-23-4098
State	Published - Aug 1 2024

ASJC Scopus Subject Areas

General Medicine

Access to Document

10.1158/1078-0432.CCR-23-4098

Cite this

Ahluwalia, M. S., Ozair, A., Drappatz, J., Ye, X., Peng, S., Lee, M., Rath, S., Dhruv, H., Hao, Y., Berens, M. E., Walbert, T., Holdhoff, M., Lesser, G. J., Cloughesy, T. F., Sloan, A. E., Takebe, N., Couce, M., Peereboom, D. M., Nabors, B., ... Rogers, L. R. (2024). Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(15), 3167-3178. https://doi.org/10.1158/1078-0432.CCR-23-4098

Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. / Ahluwalia, Manmeet S.; Ozair, Ahmad; Drappatz, Jan et al.
In: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, No. 15, 01.08.2024, p. 3167-3178.

Research output: Contribution to journal › Article › peer-review

Ahluwalia, MS, Ozair, A, Drappatz, J, Ye, X, Peng, S, Lee, M, Rath, S, Dhruv, H, Hao, Y, Berens, ME, Walbert, T, Holdhoff, M, Lesser, GJ, Cloughesy, TF, Sloan, AE, Takebe, N, Couce, M, Peereboom, DM, Nabors, B, Wen, PY, Grossman, SA & Rogers, LR 2024, 'Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 30, no. 15, pp. 3167-3178. https://doi.org/10.1158/1078-0432.CCR-23-4098

Ahluwalia MS, Ozair A, Drappatz J, Ye X, Peng S, Lee M et al. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Aug 1;30(15):3167-3178. doi: 10.1158/1078-0432.CCR-23-4098

@article{181e065a6469487891071eec94defc61,

title = "Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT",

author = "Ahluwalia, {Manmeet S.} and Ahmad Ozair and Jan Drappatz and Xiaobu Ye and Sen Peng and Matthew Lee and Sanhita Rath and Harshil Dhruv and Yue Hao and Berens, {Michael E.} and Tobias Walbert and Matthias Holdhoff and Lesser, {Glenn J.} and Cloughesy, {Timothy F.} and Sloan, {Andrew E.} and Naoko Takebe and Marta Couce and Peereboom, {David M.} and Burt Nabors and Wen, {Patrick Y.} and Grossman, {Stuart A.} and Rogers, {Lisa R.}",

note = "Publisher Copyright: {\textcopyright}2024 American Association for Cancer Research.",

year = "2024",

month = aug,

day = "1",

doi = "10.1158/1078-0432.CCR-23-4098",

language = "English",

volume = "30",

pages = "3167--3178",

journal = "Clinical cancer research : an official journal of the American Association for Cancer Research",

issn = "1078-0432",

number = "15",

}

TY - JOUR

T1 - Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

AU - Ahluwalia, Manmeet S.

AU - Ozair, Ahmad

AU - Drappatz, Jan

AU - Ye, Xiaobu

AU - Peng, Sen

AU - Lee, Matthew

AU - Rath, Sanhita

AU - Dhruv, Harshil

AU - Hao, Yue

AU - Berens, Michael E.

AU - Walbert, Tobias

AU - Holdhoff, Matthias

AU - Lesser, Glenn J.

AU - Cloughesy, Timothy F.

AU - Sloan, Andrew E.

AU - Takebe, Naoko

AU - Couce, Marta

AU - Peereboom, David M.

AU - Nabors, Burt

AU - Wen, Patrick Y.

AU - Grossman, Stuart A.

AU - Rogers, Lisa R.

PY - 2024/8/1

Y1 - 2024/8/1

UR - http://www.scopus.com/inward/record.url?scp=85200423862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85200423862&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-23-4098

DO - 10.1158/1078-0432.CCR-23-4098

M3 - Article

C2 - 38836759

AN - SCOPUS:85200423862

SN - 1078-0432

VL - 30

SP - 3167

EP - 3178

JO - Clinical cancer research : an official journal of the American Association for Cancer Research

JF - Clinical cancer research : an official journal of the American Association for Cancer Research

IS - 15

ER -

Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this